Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan.

Huang H, Peng X, Nakajima J.

Biosci Trends. 2013 Aug;7(4):172-7. Review.

2.

The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.

Samukawa T, Hamada T, Uto H, Yanagi M, Tsukuya G, Nosaki T, Maeda M, Hirano T, Tsubouchi H, Inoue H.

BMC Pulm Med. 2012 Sep 11;12:55. doi: 10.1186/1471-2466-12-55.

3.

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.

Hamai K, Iwamoto H, Ishikawa N, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Hattori N, Kohno N.

Dis Markers. 2016;2016:4759040. doi: 10.1155/2016/4759040. Epub 2016 May 17.

4.

Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.

Kobayashi H, Kanoh S, Motoyoshi K.

Biomarkers. 2008 Jun;13(4):385-92. doi: 10.1080/13547500801903651 .

PMID:
18595202
5.

Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.

Ishikawa T, Kubota T, Abe H, Hirose K, Nagashima A, Togashi T, Seki K, Honma T, Yoshida T, Kamimura T.

Hepatogastroenterology. 2012 Oct;59(119):2260-3. doi: 10.5754/hge10868.

PMID:
23435141
6.

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N.

Am J Respir Crit Care Med. 2002 Feb 1;165(3):378-81.

PMID:
11818324
7.

Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.

Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin DP, Silver RM; Scleroderma Lung Study Research Group.

J Rheumatol. 2009 Apr;36(4):773-80. doi: 10.3899/jrheum.080633. Epub 2009 Mar 13.

PMID:
19286849
8.

The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.

Okamoto T, Fujii M, Furusawa H, Tsuchiya K, Miyazaki Y, Inase N.

Respir Med. 2015 Dec;109(12):1576-81. doi: 10.1016/j.rmed.2015.10.005. Epub 2015 Oct 16.

PMID:
26481343
9.

[Lung injury and serum markers].

Suwabe A.

Rinsho Byori. 2002 Nov;50(11):1061-6. Japanese.

PMID:
12491603
10.

[Comparison of biomarkers of pulmonary tuberculosis activity --serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate].

Enomoto Y, Hagiwara E, Komatsu S, Nishihira R, Baba T, Ogura T.

Kekkaku. 2014 Jul;89(7):637-42. Japanese.

PMID:
25195297
11.

[Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].

Suematsu E, Miyamura T, Shimada H, Nakao R, Yamamoto M.

Ryumachi. 2003 Feb;43(1):11-8. Japanese.

PMID:
12692985
13.

Idiopathic pleuroparenchymal fibroelastosis is characterized by an elevated serum level of surfactant protein-D, but Not Krebs von den Lungen-6.

Sato S, Hanibuchi M, Fukuya A, Yabuki Y, Bando H, Yoshijima T, Goto H, Ogawa H, Nishioka Y.

Lung. 2014 Oct;192(5):711-7. doi: 10.1007/s00408-014-9599-0. Epub 2014 Jun 1.

PMID:
24880792
14.

Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D.

Takahashi H, Shiratori M, Kanai A, Chiba H, Kuroki Y, Abe S.

Respirology. 2006 Jan;11 Suppl:S51-4.

PMID:
16423272
15.

Serum heat shock protein 47 levels in patients with drug-induced lung disease.

Kakugawa T, Yokota S, Ishimatsu Y, Hayashi T, Nakashima S, Hara S, Sakamoto N, Matsuoka Y, Kubota H, Mine M, Mukae H, Nagata K, Kohno S.

Respir Res. 2013 Nov 20;14:133. doi: 10.1186/1465-9921-14-133.

16.

Elevation of serum KL-6 glycoprotein or surfactant protein-D in adult T-cell leukemia with distinct pulmonary complications.

Osaka A, Yanagihara K, Yamada Y, Hasegawa H, Inokuchi N, Hayashi T, Komoda M, Nakamura S, Aoyama M, Sawada T, Kamihira S.

Tohoku J Exp Med. 2009 Jun;218(2):99-105.

17.

Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.

Song JW, Do KH, Jang SJ, Colby TV, Han S, Kim DS.

Chest. 2013 May;143(5):1422-1429. doi: 10.1378/chest.11-2735.

PMID:
23715088
18.

[Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].

Ogawa N, Shimoyama K, Kawabata H, Masaki Y, Wano Y, Sugai S.

Ryumachi. 2003 Feb;43(1):19-28. Japanese.

PMID:
12692986
19.
20.

Gefitinib-induced interstitial lung disease showing improvement after cessation: disassociation of serum markers.

Kitajima H, Takahashi H, Harada K, Kanai A, Inomata S, Taniguchi H, Saikai T, Abe S.

Respirology. 2006 Mar;11(2):217-20.

PMID:
16548909

Supplemental Content

Support Center